Pictet Asset Management (UK)’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $26.2M | Buy |
336,845
+54,760
| +19% | +$4.26M | 0.03% | 465 |
|
|
2021
Q1 | $21M | Sell |
282,085
-201,227
| -42% | -$15M | 0.03% | 486 |
|
|
2020
Q4 | $82.4M | Sell |
483,312
-40,987
| -8% | -$6.99M | 0.11% | 233 |
|
|
2020
Q3 | $73.6M | Sell |
524,299
-189,221
| -27% | -$26.6M | 0.12% | 212 |
|
|
2020
Q2 | $114M | Buy |
713,520
+209,226
| +41% | +$33.5M | 0.2% | 152 |
|
|
2020
Q1 | $49.3M | Sell |
504,294
-3,085
| -0.6% | -$302K | 0.11% | 223 |
|
|
2019
Q4 | $65.5M | Sell |
507,379
-171,472
| -25% | -$22.1M | 0.12% | 217 |
|
|
2019
Q3 | $51.1M | Buy |
678,851
+220,668
| +48% | +$16.6M | 0.11% | 219 |
|
|
2019
Q2 | $69.6M | Buy |
458,183
+189,628
| +71% | +$28.8M | 0.15% | 179 |
|
|
2019
Q1 | $32M | Buy |
268,555
+2,423
| +0.9% | +$289K | 0.07% | 301 |
|
|
2018
Q4 | $29K | Sell |
266,132
-4,923
| -2% | -$537 | 0.07% | 306 |
|
|
2018
Q3 | $43.8M | Sell |
271,055
-45,284
| -14% | -$7.31M | 0.09% | 262 |
|
|
2018
Q2 | $41.8M | Sell |
316,339
-184,567
| -37% | -$24.4M | 0.1% | 254 |
|
|
2018
Q1 | $37.1M | Buy |
500,906
+460,706
| +1,146% | +$34.1M | 0.09% | 278 |
|
|
2017
Q4 | $2.24M | Buy |
40,200
+3,800
| +10% | +$211K | 0.01% | 792 |
|
|
2017
Q3 | $1.65M | Sell |
36,400
-34,700
| -49% | -$1.57M | ﹤0.01% | 804 |
|
|
2017
Q2 | $2.12M | Buy |
71,100
+3,500
| +5% | +$104K | 0.01% | 777 |
|
|
2017
Q1 | $2M | Buy |
67,600
+13,400
| +25% | +$397K | 0.01% | 773 |
|
|
2016
Q4 | $1.49M | Buy |
+54,200
| New | +$1.49M | 0.01% | 780 |
|
|
2015
Q4 | – | Sell |
-18,900
| Closed | -$607K | – | 868 |
|
|
2015
Q3 | $607K | Buy |
+18,900
| New | +$607K | ﹤0.01% | 818 |
|